Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 623

1.

Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction.

Salvioni E, Corrà U, Piepoli M, Rovai S, Correale M, Paolillo S, Pasquali M, Magrì D, Vitale G, Fusini L, Mapelli M, Vignati C, Lagioia R, Raimondo R, Sinagra G, Boggio F, Cangiano L, Gallo G, Magini A, Contini M, Palermo P, Apostolo A, Pezzuto B, Bonomi A, Scardovi AB, Filardi PP, Limongelli G, Metra M, Scrutinio D, Emdin M, Piccioli L, Lombardi C, Cattadori G, Parati G, Caravita S, Re F, Cicoira M, Frigerio M, Clemenza F, Bussotti M, Battaia E, Guazzi M, Bandera F, Badagliacca R, Di Lenarda A, Pacileo G, Passino C, Sciomer S, Ambrosio G, Agostoni P; MECKI score research group.

ESC Heart Fail. 2020 Jan 1. doi: 10.1002/ehf2.12582. [Epub ahead of print]

2.

Effects of left ventricular assist device on cardiopulmonary exercise performance.

Trombara F, Apostolo A, Vignati C, Naliato M, Ceriani R, Agostoni P.

Eur J Heart Fail. 2019 Dec 21. doi: 10.1002/ejhf.1680. [Epub ahead of print] No abstract available.

PMID:
31863566
3.

Increased serum uric acid level predicts poor prognosis in mildly severe chronic heart failure with reduced ejection fraction. An analysis from the MECKI score research group.

Piepoli MF, Salvioni E, Corrà U, Doni F, Bonomi A, La Gioia R, Limongelli G, Paolillo S, Sinagra G, Scardovi AB, Raimondo R, Emdin M, Re F, Cicoira M, Correale M, Badagliacca R, Clemenza F, Lombardi C, Agostoni P.

Eur J Intern Med. 2019 Nov 28. pii: S0953-6205(19)30390-5. doi: 10.1016/j.ejim.2019.11.003. [Epub ahead of print]

PMID:
31787490
4.

Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction.

Rovai S, Corrà U, Piepoli M, Vignati C, Salvioni E, Bonomi A, Mattavelli I, Arcari L, Scardovi AB, Perrone Filardi P, Lagioia R, Paolillo S, Magrì D, Limongelli G, Metra M, Senni M, Scrutinio D, Raimondo R, Emdin M, Lombardi C, Cattadori G, Parati G, Re F, Cicoira M, Villani GQ, Minà C, Correale M, Frigerio M, Perna E, Mapelli M, Magini A, Clemenza F, Bussotti M, Battaia E, Guazzi M, Bandera F, Badagliacca R, Di Lenarda A, Pacileo G, Maggioni A, Passino C, Sciomer S, Sinagra G, Agostoni P; MECKI Score Research Group (see Appendix 1).

Eur J Heart Fail. 2019 Dec;21(12):1586-1595. doi: 10.1002/ejhf.1595. Epub 2019 Nov 28.

PMID:
31782225
5.

Haemodynamic Balance in Acute and Advanced Heart Failure: An Expert Perspective on the Role of Levosimendan.

Agostoni P, Farmakis DT, García-Pinilla JM, Harjola VP, Karason K, von Lewinski D, Parissis J, Pollesello P, Pölzl G, Recio-Mayoral A, Reinecke A, Yerly P, Zima E.

Card Fail Rev. 2019 Nov 4;5(3):155-161. doi: 10.15420/cfr.2019.01.R1. eCollection 2019 Nov. Review.

6.

(Bi-)ulnar access for percutaneous intervention of coronary chronic total occlusion: A case series.

Budassi S, Zivelonghi C, Scott B, Agostoni P.

Cardiovasc Revasc Med. 2019 Oct 21. pii: S1553-8389(19)30667-0. doi: 10.1016/j.carrev.2019.10.014. [Epub ahead of print]

PMID:
31761639
7.

Rationale, Experimental Data, and Emerging Clinical Evidence on Early and Preventive Use of Levosimendan in Patients with Ventricular Dysfunction.

Cosentino N, Niccoli G, Fracassi F, Rebuzzi A, Agostoni P, Marenzi G.

Eur Heart J Cardiovasc Pharmacother. 2019 Nov 5. pii: pvz065. doi: 10.1093/ehjcvp/pvz065. [Epub ahead of print]

PMID:
31688906
8.

The Wrong Drug That Led to the Right Diagnosis.

Bergonti M, Assanelli E, Agostoni P.

Circulation. 2019 Nov 5;140(19):1601-1604. doi: 10.1161/CIRCULATIONAHA.119.042775. Epub 2019 Nov 4. No abstract available.

PMID:
31682531
9.

A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus.

Farmakis D, Agostoni P, Baholli L, Bautin A, Comin-Colet J, Crespo-Leiro MG, Fedele F, García-Pinilla JM, Giannakoulas G, Grigioni F, Gruchała M, Gustafsson F, Harjola VP, Hasin T, Herpain A, Iliodromitis EK, Karason K, Kivikko M, Liaudet L, Ljubas-Maček J, Marini M, Masip J, Mebazaa A, Nikolaou M, Ostadal P, Põder P, Pollesello P, Polyzogopoulou E, Pölzl G, Tschope C, Varpula M, von Lewinski D, Vrtovec B, Yilmaz MB, Zima E, Parissis J.

Int J Cardiol. 2019 Dec 15;297:83-90. doi: 10.1016/j.ijcard.2019.09.005. Epub 2019 Sep 6.

10.

Conventional vascular access site approach versus fully trans-wrist approach for chronic total occlusion percutaneous coronary intervention: a multicenter registry.

Poletti E, Azzalini L, Ayoub M, Ojeda S, Zivelonghi C, La Manna A, Bellini B, Lostalo A, Luque A, Venuti G, Montorfano M, Agostoni P, Pan M, Carlino M, Mashayekhi K.

Catheter Cardiovasc Interv. 2019 Oct 9. doi: 10.1002/ccd.28513. [Epub ahead of print]

PMID:
31596537
11.

Prediction of peak oxygen uptake by an endurance test: A wish and a nightmare.

Agostoni P, Salvioni E, Cattadori G.

Eur J Prev Cardiol. 2019 Oct 4:2047487319878799. doi: 10.1177/2047487319878799. [Epub ahead of print] No abstract available.

PMID:
31583892
12.

3-Year Clinical Outcomes of the PRISON-IV Trial: Ultrathin Struts Versus Conventional Drug-Eluting Stents in Total Coronary Occlusions.

Zivelonghi C, Agostoni P, Teeuwen K, van der Schaaf RJ, Henriques JPS, Vermeersch PHMJ, Bosschaert MAR, Kelder JC, Tijssen JGP, Suttorp MJ.

JACC Cardiovasc Interv. 2019 Sep 9;12(17):1747-1749. doi: 10.1016/j.jcin.2019.05.044. No abstract available.

PMID:
31488307
13.

Cardiac implantable electronic devices with a defibrillator component and all-cause mortality in left ventricular assist device carriers: results from the PCHF-VAD registry.

Cikes M, Jakus N, Claggett B, Brugts JJ, Timmermans P, Pouleur AC, Rubis P, Van Craenenbroeck EM, Gaizauskas E, Grundmann S, Paolillo S, Barge-Caballero E, D'Amario D, Gkouziouta A, Planinc I, Veenis JF, Jacquet LM, Houard L, Holcman K, Gigase A, Rega F, Rucinskas K, Adamopoulos S, Agostoni P, Biocina B, Gasparovic H, Lund LH, Flammer AJ, Metra M, Milicic D, Ruschitzka F; PCHF-VAD registry.

Eur J Heart Fail. 2019 Sep;21(9):1129-1141. doi: 10.1002/ejhf.1568. Epub 2019 Aug 13.

14.

Ghrelin Derangements in Idiopathic Dilated Cardiomyopathy: Impact of Myocardial Disease Duration and Left Ventricular Ejection Fraction.

Aleksova A, Beltrami AP, Bevilacqua E, Padoan L, Santon D, Biondi F, Barbati G, Stenner E, Gortan Cappellari G, Barazzoni R, Ziberna F, Zwas DR, Avraham Y, Agostoni P, Not T, Livi U, Sinagra G.

J Clin Med. 2019 Aug 1;8(8). pii: E1152. doi: 10.3390/jcm8081152.

15.

Reply to the letter regarding: "Incomplete coronary sinus reducer endothelialisation as potential mechanism of clinical failure".

Zivelonghi C, Vermeersch G, Verheye S, Agostoni P.

Catheter Cardiovasc Interv. 2019 Jul 31. doi: 10.1002/ccd.28416. [Epub ahead of print] No abstract available.

PMID:
31364791
16.

Regional differences in exercise training implementation in heart failure: findings from the Exercise Training in Heart Failure (ExTraHF) survey.

Piepoli MF, Binno S, Coats AJS, Cohen-Solal A, Corrà U, Davos CH, Jaarsma T, Lund L, Niederseer D, Orso F, Villani GQ, Agostoni P, Volterrani M, Seferovic P; Committee on Exercise Physiology & Training of the Heart Failure Association of the European Society of Cardiology.

Eur J Heart Fail. 2019 Sep;21(9):1142-1148. doi: 10.1002/ejhf.1538. Epub 2019 Jul 25.

PMID:
31343108
17.

Pro-oxidant and pro-inflammatory effects of glycated albumin on cardiomyocytes.

Martinez Fernandez A, Regazzoni L, Brioschi M, Gianazza E, Agostoni P, Aldini G, Banfi C.

Free Radic Biol Med. 2019 Nov 20;144:245-255. doi: 10.1016/j.freeradbiomed.2019.06.023. Epub 2019 Jun 28.

18.

Coronary artery perforation during chronic total occlusion percutaneous coronary intervention: epidemiology, mechanisms, management, and outcomes.

Azzalini L, Poletti E, Ayoub M, Ojeda S, Zivelonghi C, La Manna A, Bellini B, Lostalo A, Luque A, Venuti G, Montorfano M, Agostoni P, Pan M, Carlino M, Mashayekhi K.

EuroIntervention. 2019 Oct 4;15(9):e804-e811. doi: 10.4244/EIJ-D-19-00282.

19.

Cost-effectiveness of the coronary sinus Reducer and its impact on the healthcare burden of refractory angina patients.

Gallone G, Armeni P, Verheye S, Agostoni P, Timmers L, Campo G, Ielasi A, Sgura F, Tarantini G, Rosseel L, Zivelonghi C, Leenders G, Stella P, Tebaldi M, Tespili M, D'Amico G, Baldetti L, Ponticelli F, Colombo A, Giannini F.

Eur Heart J Qual Care Clin Outcomes. 2019 May 24. pii: qcz027. doi: 10.1093/ehjqcco/qcz027. [Epub ahead of print]

PMID:
31124556
20.

Anemia and Iron Deficiency in Heart Failure: Clinical and Prognostic Role.

Magrì D, De Martino F, Moscucci F, Agostoni P, Sciomer S.

Heart Fail Clin. 2019 Jul;15(3):359-369. doi: 10.1016/j.hfc.2019.02.005. Epub 2019 Apr 5. Review.

PMID:
31079694

Supplemental Content

Loading ...
Support Center